These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21051618)

  • 1. Cancer. Awakening immunity.
    Schreiber H; Rowley DA
    Science; 2010 Nov; 330(6005):761-2. PubMed ID: 21051618
    [No Abstract]   [Full Text] [Related]  

  • 2. News & views in ... Immunotherapy.
    Immunotherapy; 2011 Jan; 3(1):5-7. PubMed ID: 21174550
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
    Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
    Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
    Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha.
    Kraman M; Bambrough PJ; Arnold JN; Roberts EW; Magiera L; Jones JO; Gopinathan A; Tuveson DA; Fearon DT
    Science; 2010 Nov; 330(6005):827-30. PubMed ID: 21051638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model.
    Wen Y; Wang CT; Ma TT; Li ZY; Zhou LN; Mu B; Leng F; Shi HS; Li YO; Wei YQ
    Cancer Sci; 2010 Nov; 101(11):2325-32. PubMed ID: 20804499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
    Yang X; Chu Y; Wang Y; Zhang R; Xiong S
    J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
    Yasuda M; Takenoyama M; Obata Y; Sugaya M; So T; Hanagiri T; Sugio K; Yasumoto K
    Cancer Res; 2002 Mar; 62(6):1751-6. PubMed ID: 11912150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting angiogenesis within the tumor microenvironment: the secret life of murine lymphoid IL-17-producing gammadelta T cells.
    Silva-Santos B
    Eur J Immunol; 2010 Jul; 40(7):1873-6. PubMed ID: 20549671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses.
    Uekusa Y; Gao P; Yamaguchi N; Tomura M; Mukai T; Nakajima C; Iwasaki M; Takeuchi N; Tsujimura T; Nakazawa M; Fujiwara H; Hamaoka T
    J Leukoc Biol; 2002 Nov; 72(5):864-73. PubMed ID: 12429708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer. Quo vadis, specificity?
    Schreiber H; Rowley DA
    Science; 2008 Jan; 319(5860):164-5. PubMed ID: 18187644
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
    Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
    Salih HR; Nüssler V
    Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.
    Savage PA; Vosseller K; Kang C; Larimore K; Riedel E; Wojnoonski K; Jungbluth AA; Allison JP
    Science; 2008 Jan; 319(5860):215-20. PubMed ID: 18187659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
    Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
    J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow.
    Bae S; Park CW; Son HK; Ju HK; Paik D; Jeon CJ; Koh GY; Kim J; Kim H
    Br J Haematol; 2008 Sep; 142(5):827-30. PubMed ID: 18510677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape mechanisms in tumor immunity: an update.
    Müller L; Kiessling R; Rees RC; Pawelec G
    J Environ Pathol Toxicol Oncol; 2002; 21(4):277-330. PubMed ID: 12510961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
    Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
    Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenetic variants of mouse tumor cells obtained by mutagenesis].
    Boon T
    Bull Mem Acad R Med Belg; 1980; 135(10):674-83. PubMed ID: 6974026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.